Michelle Mendoza, pharmacy technician, reconstitutes the remdesivir research drug under an intravenous hood at Brooke Army Medical Center, Joint Base San Antonio-Fort Sam Houston, April 29. BAMC is participating in a COVID-19 treatment trial centering on the anti-viral drug, remdesivir. The National Institute of Allergy and Infectious Diseases (NIAID)-sponsored study enrolled more than a thousand people across the nation as it looked to determine if the antiviral drug is effective against COVID-19.
CAMERA
NIKON D810
LENS
28.0-300.0 mm f/3.5-5.6
APERTURE
63/10
SHUTTERSPEED
1/125
ISO
100
No camera details available.
This photograph is considered public domain and has been cleared for release. If you would like to republish please give the photographer appropriate credit. Further, any commercial or non-commercial use of this photograph or any other DoD image must be made in compliance with guidance found at https://www.dimoc.mil/resources/limitations, which pertains to intellectual property restrictions (e.g., copyright and trademark, including the use of official emblems, insignia, names and slogans), warnings regarding use of images of identifiable personnel, appearance of endorsement, and related matters.